Legend Biotech Corporation

08/11/2026 | Press release | Distributed by Public on 08/11/2026 05:54

Supplemental Risk Factor (Form 6-K)

Any of these outcomes could affect our financial position and overall or effective tax rates in the future in countries where we have operations, reduce post-tax returns to our shareholders, and increase the complexity, burden and cost of tax compliance.

Legend Biotech Corporation published this content on August 11, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on August 11, 2026 at 11:54 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]